Five years after the publication of the initial sequence of the human genome, it has been uncovered that this sequence is not identical among different individuals and that the existing variability is ten times greater than it was supposed in the initial studies. Up to now it was thought that each person differed from another in a million of the more than 3 billion nucleotides (the letters in which information is encrypted in the genome sequence: A, C, G and T) that compose the human genome.
A study carried out by a Consortium of American, Spanish, Canadian, British and Japanese investigators has revealed that any two people differ in more than 20 million nucleotides, that are grouped in at least 1.400 discrete regions of the genome.
The difference between a person and another is not in the sequence itself but in a varying number of copies. Those regions, that are termed "Copy Number Variants" or CNVs, suppose more than 360 million differences with respect to the original sequence published in early 2003 by the International Human Genome Project Consortium.
The study of the structural variation of the human genome will be published in Nature, in the issue of November 23rd. This research, carried out in samples coming from individuals of Asian, African and European ancestry, represents the most exhaustive study of large-scale variability thus far published, after the definition of the reference sequence of the human genome and the study of nucleotide diversity (HapMap), published in this same journal by the end of 2005.
The work clearly shows that it does not exist a unique sequence of the human genome, but a plethora of different sequences. The 1.400 variable regions reported do indeed contain genes, besides of other functional structures, and many of them correspond to regions involved in human diseases, such as muscular dystrophies, renal and many other developmental disorders. Besides, the regions that have been detected do contain variants that could confer sensitivity or resistance for many common diseases that affect the population, like AIDS or the systemic lupus erythematosus (SLE), among others. The results of this investigation uncover a new dimension of the complexity of the human genome, unexpected and unexplored until now.
The discovery opens the doors to numerous studies to define the causes of many human diseases, to develop more efficient pharmacological processes and to develop prenatal screening methods, which will completely change the current methodologies for the prenatal diagnostic.
Local investigators, Lluis Armengol, Juan Ramon Gonzalez, Monica Gratacos and Xavier Estivill, from the group of Genetic Causes of Disease of the Program Genes and Disease, at the Centre for Genomic Regulation (CRG) are part of the international consortium and have participated in the work. The Spanish contribution to this research project has been supported by the Foundation Genome Spain.
Gloria Lligadas | alfa
The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences
Transforming plant cells from generalists to specialists
07.12.2016 | Duke University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine